Skip to main content

Home > Releases > Quarterly Financial Report > Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Retained Earnings at Beginning of Quarter

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Retained Earnings at Beginning of Quarter (QFRD119385USNO)

Observations

Q1 2025: 368,156
Updated: Jun 10, 2025 9:11 AM CDT
Q1 2025:  368,156  
Q4 2024:  381,601  
Q3 2024:  375,452  
Q2 2024:  362,469  
Q1 2024:  372,917  

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

Fullscreen

Notes

Title Release Dates
Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Retained Earnings at Beginning of Quarter 2017-09-06 2025-06-10
 
Source    
U.S. Census Bureau 2017-09-06 2025-06-10
 
Release    
Quarterly Financial Report 2017-09-06 2025-06-10
 
Units    
Millions of Dollars 2017-09-06 2025-06-10
 
Frequency    
Quarterly 2017-09-06 2025-06-10
 
Seasonal Adjustment    
Not Seasonally Adjusted 2017-09-06 2025-06-10
 
Notes    
Further information related to the Quarterly Financial Report survey can be found at https://www.census.gov/econ/qfr/about.html
Methodology details can be found at https://www.census.gov/econ/qfr/documents/QFR_Methodology.pdf

2017-09-06 2025-06-10

Release Tables

Quarterly Financial Report

Related Data and Content

Data Suggestions Based On Your Search

Content Suggestions

Related Categories

Financial Activity Measures Financial Indicators Money, Banking, & Finance

Releases

More Series from Quarterly Financial Report

Tags

retained earnings Medicines Pharmaceuticals Quarterly Financial Report Chemicals Finance Nondurable Goods Earnings Corporate Goods Manufacturing Industry Quarterly Census Nation Public Domain: Citation Requested Not Seasonally Adjusted United States of America